ONTOLOGY REPORT - ANNOTATIONS
| Term: | ouabain |
|
| Accession: | CHEBI:472805
|
browse the term
|
| Definition: | A multi-hydroxylated alpha-L-rhamnosyl cardenoloide. It binds to and inhibits the plasma membrane Na(+(/K)+)-ATPase (sodium pump). |
| Synonyms: | exact_synonym: | 3-(6-deoxy-alpha-L-mannopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide |
| | related_synonym: | 3-(alpha-L-rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide; C29H44O12; G-Strophanthin; InChI=1S/C29H44O12/c1-13-22(34)23(35)24(36)25(40-13)41-15-8-19(32)28(12-30)21-17(3-5-27(28,37)9-15)29(38)6-4-16(14-7-20(33)39-11-14)26(29,2)10-18(21)31/h7,13,15-19,21-25,30-32,34-38H,3-6,8-12H2,1-2H3/t13-,15-,16+,17+,18+,19+,21+,22-,23+,24+,25-,26+,27-,28+,29-/m0/s1; InChIKey=LPMXVESGRSUGHW-HBYQJFLCSA-N; Ouabagenin L-Rhamnoside; Ouabagenin-L-rhamnosid; Ouabain anhydrous; Ouabaine; Oubain; Strodival; [H][C@@]12CC[C@]3(O)C[C@H](C[C@@H](O)[C@]3(CO)[C@@]1([H])[C@H](O)C[C@]1(C)[C@H](CC[C@]21O)C1=CC(=O)OC1)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O |
| | alt_id: | CHEBI:44461; CHEBI:7805 |
| | xref_casrn: | 630-60-4 |
| | xref: | Beilstein:101712 "Beilstein Registry Number"; ChEMBL:472805 "ChEMBL COMPOUND"; ChemIDplus:630-60-4 "CAS Registry Number"; CiteXplore:10438974 "PubMed citation"; DrugBank:DB01092 "DrugBank"; KEGG COMPOUND:630-60-4 "CAS Registry Number"; KEGG COMPOUND:C01443 "KEGG COMPOUND"; KEGG DRUG:D00112 "KEGG DRUG" |
| | xref_mesh: | MESH:D010042 |
| | xref: | PDBeChem:OBN "PDBeChem" |
|
|
ouabain
|
| G |
A2m |
alpha-2-macroglobulin |
|
affects expression |
ISO |
4 |
158,103,711 |
158,153,423 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
|
affects expression |
ISO |
18 |
71,587,259 |
71,632,610 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
affects expression |
EXP |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
affects expression |
ISO |
2 |
235,799,396 |
235,811,584 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
affects expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
decreases expression |
EXP |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
affects expression |
EXP |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Anxa1 |
annexin A1 |
|
affects expression |
ISO |
1 |
223,478,436 |
223,494,455 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
affects expression |
ISO |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Araf |
v-raf murine sarcoma 3611 viral oncogene homolog |
|
decreases expression |
ISO |
X |
12,556,904 |
12,568,583 |
RGD:6480464 |
CTD |
| G |
Arih1 |
ariadne homolog, ubiquitin-conjugating enzyme E2 binding protein, 1 (Drosophila) |
|
decreases expression |
ISO |
8 |
63,201,871 |
63,305,302 |
RGD:6480464 |
CTD |
| G |
Arpc5 |
actin related protein 2/3 complex, subunit 5 |
|
affects expression |
ISO |
13 |
67,755,352 |
67,764,261 |
RGD:6480464 |
CTD |
| G |
Arrb1 |
arrestin, beta 1 |
|
increases expression |
ISO |
1 |
156,871,564 |
156,937,540 |
RGD:6480464 |
CTD |
| G |
Asah1 |
N-acylsphingosine amidohydrolase (acid ceramidase) 1 |
|
affects expression |
ISO |
16 |
54,279,253 |
54,311,084 |
RGD:6480464 |
CTD |
| G |
Atp12a |
ATPase, H+/K+ transporting, nongastric, alpha polypeptide |
|
multiple interactions |
ISO |
15 |
35,295,274 |
35,321,453 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
multiple interactions |
ISO |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
affects binding |
ISO |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
increases expression |
ISO |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
affects expression |
EXP |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
increases expression |
EXP |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
increases expression |
EXP |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
multiple interactions |
ISO |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
affects binding |
ISO |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
increases expression |
ISO |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
affects response to substance |
ISO |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
multiple interactions |
ISO |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
decreases activity |
ISO |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
multiple interactions |
EXP |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
affects expression |
EXP |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
decreases expression |
EXP |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
increases expression |
EXP |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
increases expression |
EXP |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1a2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
affects response to substance |
ISO |
13 |
88,258,993 |
88,283,918 |
RGD:6480464 |
CTD |
| G |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
|
increases expression |
ISO |
1 |
80,280,714 |
80,309,834 |
RGD:6480464 |
CTD |
| G |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
|
affects binding |
ISO |
1 |
80,280,714 |
80,309,834 |
RGD:6480464 |
CTD |
| G |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
|
multiple interactions |
EXP |
1 |
80,280,714 |
80,309,834 |
RGD:6480464 |
CTD |
| G |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
|
affects expression |
EXP |
1 |
80,280,714 |
80,309,834 |
RGD:6480464 |
CTD |
| G |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
|
decreases expression |
EXP |
1 |
80,280,714 |
80,309,834 |
RGD:6480464 |
CTD |
| G |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
|
decreases expression |
EXP |
1 |
80,280,714 |
80,309,834 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
multiple interactions |
EXP |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
increases expression |
EXP |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp4b |
ATPase, H+/K+ exchanging, beta polypeptide |
|
multiple interactions |
ISO |
16 |
81,000,154 |
81,009,067 |
RGD:6480464 |
CTD |
| G |
Atp5a1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle |
|
affects expression |
ISO |
18 |
74,735,267 |
74,743,088 |
RGD:6480464 |
CTD |
| G |
Bahd1 |
bromo adjacent homology domain containing 1 |
|
decreases expression |
ISO |
3 |
105,429,028 |
105,437,536 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
affects localization |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Calb1 |
calbindin 1 |
|
decreases expression |
EXP |
5 |
30,455,665 |
30,480,122 |
RGD:6480464 |
CTD |
| G |
Calml5 |
calmodulin-like 5 |
|
affects expression |
ISO |
17 |
77,567,314 |
77,571,711 |
RGD:6480464 |
CTD |
| G |
Canx |
calnexin |
|
increases expression |
ISO |
10 |
35,850,944 |
35,883,494 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccdc14 |
coiled-coil domain containing 14 |
|
decreases expression |
ISO |
11 |
67,872,420 |
67,905,568 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccna1 |
cyclin A1 |
|
decreases expression |
ISO |
2 |
144,275,211 |
144,285,196 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
decreases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases expression |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases expression |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases expression |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
decreases activity |
EXP |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Cldn1 |
claudin 1 |
|
decreases expression |
ISO |
11 |
76,473,654 |
76,488,809 |
RGD:6480464 |
CTD |
| G |
Cnpy2 |
canopy 2 homolog (zebrafish) |
|
affects expression |
ISO |
7 |
1,611,268 |
1,615,873 |
RGD:6480464 |
CTD |
| G |
Cs |
citrate synthase |
|
decreases activity |
EXP |
7 |
1,626,181 |
1,652,197 |
RGD:6480464 |
CTD |
| G |
Cyc1 |
cytochrome c-1 |
|
multiple interactions |
ISO |
7 |
114,394,178 |
114,396,563 |
RGD:6480464 |
CTD |
| G |
Ddost |
dolichyl-diphosphooligosaccharide-protein glycosyltransferase |
|
decreases expression |
ISO |
5 |
157,083,337 |
157,090,071 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
decreases expression |
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Dsg1 |
desmoglein 1 |
|
affects expression |
ISO |
18 |
12,127,180 |
12,156,469 |
RGD:6480464 |
CTD |
| G |
Dut |
deoxyuridine triphosphatase |
|
affects expression |
ISO |
3 |
112,551,434 |
112,562,434 |
RGD:6480464 |
CTD |
| G |
Ece1 |
endothelin converting enzyme 1 |
|
increases expression |
ISO |
5 |
156,635,656 |
156,735,783 |
RGD:6480464 |
CTD |
| G |
Echs1 |
enoyl CoA hydratase, short chain, 1, mitochondrial |
|
affects expression |
ISO |
1 |
199,901,585 |
199,910,412 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
increases expression |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Ednra |
endothelin receptor type A |
|
increases expression |
EXP |
19 |
32,042,366 |
32,108,153 |
RGD:6480464 |
CTD |
| G |
Ednra |
endothelin receptor type A |
|
increases expression |
EXP |
19 |
32,042,366 |
32,108,153 |
RGD:6480464 |
CTD |
| G |
Ednra |
endothelin receptor type A |
|
increases expression |
EXP |
19 |
32,042,366 |
32,108,153 |
RGD:6480464 |
CTD |
| G |
Eif3k |
eukaryotic translation initiation factor 3, subunit K |
|
affects expression |
ISO |
1 |
84,083,646 |
84,088,799 |
RGD:6480464 |
CTD |
| G |
Fars2 |
phenylalanyl-tRNA synthetase 2, mitochondrial |
|
increases expression |
ISO |
17 |
34,595,255 |
35,048,596 |
RGD:6480464 |
CTD |
| G |
Fbxo32 |
F-box protein 32 |
|
multiple interactions |
ISO |
7 |
94,909,568 |
94,942,444 |
RGD:6480464 |
CTD |
| G |
Fh |
fumarate hydratase |
|
affects expression |
ISO |
13 |
91,329,837 |
91,355,722 |
RGD:6480464 |
CTD |
| G |
Fkbp7 |
FK506 binding protein 7 |
|
increases expression |
ISO |
3 |
59,361,703 |
59,373,382 |
RGD:6480464 |
CTD |
| G |
Gc |
group specific component |
|
affects expression |
ISO |
14 |
20,166,243 |
20,197,060 |
RGD:6480464 |
CTD |
| G |
Glrb |
glycine receptor, beta |
|
increases expression |
ISO |
2 |
172,451,807 |
172,522,841 |
RGD:6480464 |
CTD |
| G |
Gtpbp6 |
GTP binding protein 6 (putative) |
|
increases expression |
ISO |
12 |
46,722,131 |
46,726,000 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
multiple interactions |
EXP |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases activity |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
affects localization |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
|
affects expression |
ISO |
4 |
79,700,327 |
79,704,116 |
RGD:6480464 |
CTD |
| G |
Hnrpdl |
heterogeneous nuclear ribonucleoprotein D-like |
|
decreases expression |
ISO |
14 |
10,861,054 |
10,864,322 |
RGD:6480464 |
CTD |
| G |
Hpcal1 |
hippocalcin-like 1 |
|
affects expression |
ISO |
6 |
41,458,062 |
41,576,771 |
RGD:6480464 |
CTD |
| G |
Hrg |
histidine-rich glycoprotein |
|
affects expression |
ISO |
11 |
80,248,578 |
80,264,179 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
affects expression |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
multiple interactions |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Il2ra |
interleukin 2 receptor, alpha |
|
decreases expression |
ISO |
17 |
78,050,491 |
78,097,802 |
RGD:6480464 |
CTD |
| G |
Il2rb |
interleukin 2 receptor, beta |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kcnd2 |
potassium voltage-gated channel, Shal-related subfamily, member 2 |
|
increases expression |
ISO |
4 |
47,541,787 |
48,047,924 |
RGD:6480464 |
CTD |
| G |
Kcnd2 |
potassium voltage-gated channel, Shal-related subfamily, member 2 |
|
increases expression |
EXP |
4 |
47,541,787 |
48,047,924 |
RGD:6480464 |
CTD |
| G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
decreases expression |
ISO |
4 |
6,192,644 |
6,224,285 |
RGD:6480464 |
CTD |
| G |
Lgals1 |
lectin, galactoside-binding, soluble, 1 |
|
affects expression |
ISO |
7 |
116,893,662 |
116,896,768 |
RGD:6480464 |
CTD |
| G |
Lgals1 |
lectin, galactoside-binding, soluble, 1 |
|
increases expression |
ISO |
7 |
116,893,662 |
116,896,768 |
RGD:6480464 |
CTD |
| G |
Lss |
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) |
|
increases abundance |
ISO |
20 |
12,507,575 |
12,534,612 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk7 |
mitogen-activated protein kinase 7 |
|
multiple interactions |
ISO |
10 |
47,649,203 |
47,654,316 |
RGD:6480464 |
CTD |
| G |
Mdh2 |
malate dehydrogenase 2, NAD (mitochondrial) |
|
affects expression |
ISO |
12 |
22,021,302 |
22,034,257 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myl12a |
myosin, light chain 12A, regulatory, non-sarcomeric |
|
increases expression |
ISO |
9 |
110,190,030 |
110,197,715 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
affects expression |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
increases expression |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
affects expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Npc2 |
Niemann-Pick disease, type C2 |
|
decreases expression |
ISO |
6 |
108,793,935 |
108,814,703 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases expression |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
multiple interactions |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
multiple interactions |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Park7 |
parkinson protein 7 |
|
affects response to substance |
ISO |
5 |
168,050,149 |
168,061,616 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
decreases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
decreases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
decreases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pdcd6 |
programmed cell death 6 |
|
increases expression |
ISO |
1 |
29,769,911 |
29,785,577 |
RGD:6480464 |
CTD |
| G |
Pfdn5 |
prefoldin subunit 5 |
|
affects expression |
ISO |
7 |
141,075,469 |
141,080,207 |
RGD:6480464 |
CTD |
| G |
Pfn1 |
profilin 1 |
|
affects expression |
ISO |
10 |
57,531,661 |
57,534,366 |
RGD:6480464 |
CTD |
| G |
Pfn1 |
profilin 1 |
|
decreases expression |
ISO |
10 |
57,531,661 |
57,534,366 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
affects expression |
ISO |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Ppt2 |
palmitoyl-protein thioesterase 2 |
|
decreases expression |
ISO |
20 |
4,225,630 |
4,234,653 |
RGD:6480464 |
CTD |
| G |
Psmb6 |
proteasome (prosome, macropain) subunit, beta type 6 |
|
affects expression |
ISO |
10 |
57,370,397 |
57,372,704 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
|
decreases expression |
ISO |
18 |
64,205,920 |
64,271,288 |
RGD:6480464 |
CTD |
| G |
Rab11b |
RAB11B, member RAS oncogene family |
|
increases expression |
ISO |
7 |
16,232,840 |
16,246,007 |
RGD:6480464 |
CTD |
| G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
|
increases cleavage |
ISO |
18 |
1,391,751 |
1,511,865 |
RGD:6480464 |
CTD |
| G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
|
multiple interactions |
ISO |
18 |
1,391,751 |
1,511,865 |
RGD:6480464 |
CTD |
| G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
|
multiple interactions |
ISO |
6 |
40,581,247 |
40,672,854 |
RGD:6480464 |
CTD |
| G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
|
increases cleavage |
ISO |
6 |
40,581,247 |
40,672,854 |
RGD:6480464 |
CTD |
| G |
Rpa3 |
replication protein A3 |
|
affects expression |
ISO |
4 |
33,304,334 |
33,307,365 |
RGD:6480464 |
CTD |
| G |
Rpgrip1l |
Rpgrip1-like |
|
decreases expression |
ISO |
19 |
16,859,114 |
16,952,054 |
RGD:6480464 |
CTD |
| G |
Ryr2 |
ryanodine receptor 2, cardiac |
|
multiple interactions |
ISO |
17 |
68,959,042 |
69,544,816 |
RGD:6480464 |
CTD |
| G |
Ryr2 |
ryanodine receptor 2, cardiac |
|
increases response to substance |
ISO |
17 |
68,959,042 |
69,544,816 |
RGD:6480464 |
CTD |
| G |
S100a13 |
S100 calcium binding protein A13 |
|
affects expression |
ISO |
2 |
182,790,173 |
182,796,668 |
RGD:6480464 |
CTD |
| G |
S100b |
S100 calcium binding protein B |
|
increases expression |
EXP |
20 |
12,791,440 |
12,824,508 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
multiple interactions |
ISO |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
|
multiple interactions |
ISO |
3 |
153,849,825 |
153,890,111 |
RGD:6480464 |
CTD |
| G |
Slc22a12 |
solute carrier family 22 (organic anion/urate transporter), member 12 |
|
multiple interactions |
ISO |
1 |
209,320,804 |
209,327,918 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a6 |
solute carrier family 5 (sodium-dependent vitamin transporter), member 6 |
|
multiple interactions |
ISO |
6 |
25,301,630 |
25,312,901 |
RGD:6480464 |
CTD |
| G |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
|
affects response to substance |
ISO |
6 |
4,421,046 |
4,691,716 |
RGD:6480464 |
CTD |
| G |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
|
multiple interactions |
EXP |
6 |
4,421,046 |
4,691,716 |
RGD:6480464 |
CTD |
| G |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
|
multiple interactions |
EXP |
6 |
4,421,046 |
4,691,716 |
RGD:6480464 |
CTD |
| G |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
|
increases expression |
EXP |
6 |
4,421,046 |
4,691,716 |
RGD:6480464 |
CTD |
| G |
Slc9a1 |
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
|
multiple interactions |
EXP |
5 |
151,680,696 |
151,748,460 |
RGD:6480464 |
CTD |
| G |
Slc9a1 |
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
|
increases expression |
EXP |
5 |
151,680,696 |
151,748,460 |
RGD:6480464 |
CTD |
| G |
Tpi1 |
triosephosphate isomerase 1 |
|
affects expression |
ISO |
4 |
160,933,341 |
160,936,871 |
RGD:6480464 |
CTD |
| G |
Tpt1 |
tumor protein, translationally-controlled 1 |
|
affects expression |
ISO |
15 |
56,752,464 |
56,755,288 |
RGD:6480464 |
CTD |
| G |
Trim63 |
tripartite motif containing 63, E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
5 |
153,059,573 |
153,073,907 |
RGD:6480464 |
CTD |
| G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
|
increases expression |
EXP |
8 |
100,770,833 |
100,821,420 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases expression |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
multiple interactions |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
multiple interactions |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
affects expression |
ISO |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Zfhx3 |
zinc finger homeobox 3 |
|
decreases expression |
ISO |
19 |
38,547,428 |
38,783,613 |
RGD:6480464 |
CTD |
Term paths to the root
|